Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ruizhang Ou"'
Autor:
Chengmei Huang, Ruizhang Ou, Xiaoning Chen, Yaxin Zhang, Jiexi Li, Yihao Liang, Xiaohui Zhu, Lei Liu, Mingzhou Li, Dagui Lin, Junfeng Qiu, Guanglong Liu, Lingjie Zhang, Yuanyuan Wu, Huiyi Tang, Yanmin Liu, Li Liang, Yanqing Ding, Wenting Liao
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-17 (2021)
Abstract Background Tumor-associated macrophages (TAMs) are key regulators of the complex interplay between cancer and the immune microenvironment. Tumor cell-derived spondin 2 (SPON2) is an extracellular matrix glycoprotein that has complicated role
Externí odkaz:
https://doaj.org/article/431411549d9c4db3983cd3fcdca9e855
Autor:
Junfeng Qiu, Mingzhou Li, Cailin Su, Yihao Liang, Ruizhang Ou, Xiaoning Chen, Chengmei Huang, Yaxin Zhang, Yaping Ye, Wenting Liao, Chao Zhang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundForkhead box S1 (FOXS1) is a member of the forkhead box (FOX) transcriptional factor superfamily. The biological roles and underlying regulatory mechanism of FOXS1 in CRC remain unclear.MethodsBioinformatics analysis, Western blotting, real
Externí odkaz:
https://doaj.org/article/7cc97f49811a4d7b8f1103e2215f0347
Autor:
Liping Ye, Chuyong Lin, Xi Wang, Qiji Li, Yue Li, Meng Wang, Zekun Zhao, Xianqiu Wu, Dongni Shi, Yunyun Xiao, Liangliang Ren, Yunting Jian, Meisongzhu Yang, Ruizhang Ou, Guangzheng Deng, Ying Ouyang, Xiangfu Chen, Jun Li, Libing Song
Publikováno v:
EMBO Molecular Medicine, Vol 11, Iss 12, Pp 1-19 (2019)
Abstract Resistance to tamoxifen is a clinically major challenge in breast cancer treatment. Although downregulation of estrogen receptor‐alpha (ERα) is the dominant mechanism of tamoxifen resistance, the reason for ERα decrease during tamoxifen
Externí odkaz:
https://doaj.org/article/9d1e2d7aba0149b99b9ad9389ece5549
Autor:
Liping Ye, Chuyong Lin, Xi Wang, Qiji Li, Yue Li, Meng Wang, Zekun Zhao, Xianqiu Wu, Dongni Shi, Yunyun Xiao, Liangliang Ren, Yunting Jian, Meisongzhu Yang, Ruizhang Ou, Guangzheng Deng, Ying Ouyang, Xiangfu Chen, Jun Li, Libing Song
Publikováno v:
EMBO Molecular Medicine, Vol 14, Iss 3, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/f1c8ce0dc9d74cbf86039bb496cfa9cd
Autor:
Yanqing Ding, Yihao Liang, Jiexi Li, Dagui Lin, Lei Liu, Ruizhang Ou, Ling-Jie Zhang, Xiaohui Zhu, Mingzhou Li, Yaxin Zhang, Li Liang, Wenting Liao, Yanmin Liu, Guanglong Liu, Xiaoning Chen, Yuanyuan Wu, Jun-Feng Qiu, Chengmei Huang, Huiyi Tang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-17 (2021)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research : CR
Background Tumor-associated macrophages (TAMs) are key regulators of the complex interplay between cancer and the immune microenvironment. Tumor cell-derived spondin 2 (SPON2) is an extracellular matrix glycoprotein that has complicated roles in recr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f3c3599f7113b4588142e0e5c307f1a
https://doaj.org/article/431411549d9c4db3983cd3fcdca9e855
https://doaj.org/article/431411549d9c4db3983cd3fcdca9e855
Autor:
Yangying Ou, Xiangfu Chen, Xuehu Xu, Xin Liang, Meng Wang, Yan Zhang, Wenting Liao, Libing Song, Yunting Jian, Yanqing Ding, Ziyuan Zhu, Ruizhang Ou
Publikováno v:
Cancer Letters. 428:1-11
Jade family PHD finger 3 (JADE3) plays a role in inducing histone acetylation during transcription, and is involved in the progression of several human cancers; however, its role in colon cancer remains unclear. Herein, we found that JADE3 was marked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede44828b0cfd8826c1a86c07e2a6926
https://doi.org/10.1016/j.canlet.2018.04.012
https://doi.org/10.1016/j.canlet.2018.04.012
Autor:
Ying Ouyang, Jun Li, Xi Wang, Chuyong Lin, Guangzheng Deng, Ruizhang Ou, Xianqiu Wu, Meisongzhu Yang, Qiji Li, Xiangfu Chen, Libing Song, Zekun Zhao, Yunyun Xiao, Dongni Shi, Yunting Jian, Liping Ye, Liangliang Ren, Yue Li, Meng Wang
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, Vol 11, Iss 12, Pp n/a-n/a (2019)
EMBO Molecular Medicine, Vol 11, Iss 12, Pp n/a-n/a (2019)
Resistance to tamoxifen is a clinically major challenge in breast cancer treatment. Although downregulation of estrogen receptor‐alpha (ERα) is the dominant mechanism of tamoxifen resistance, the reason for ERα decrease during tamoxifen therapy r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d3b5f1f4ed92965a8d031cf86bdbc07
https://pubmed.ncbi.nlm.nih.gov/35253379
https://pubmed.ncbi.nlm.nih.gov/35253379
Autor:
Huang, Chengmei1,2,3 (AUTHOR), Ou, Ruizhang1,2,3 (AUTHOR), Chen, Xiaoning1,2,3 (AUTHOR), Zhang, Yaxin1,2,3 (AUTHOR), Li, Jiexi4 (AUTHOR), Liang, Yihao5 (AUTHOR), Zhu, Xiaohui1,2,3 (AUTHOR), Liu, Lei1,2,3 (AUTHOR), Li, Mingzhou1,2,3 (AUTHOR), Lin, Dagui6 (AUTHOR), Qiu, Junfeng1,2,3 (AUTHOR), Liu, Guanglong1,2,3 (AUTHOR), Zhang, Lingjie1,2,3 (AUTHOR), Wu, Yuanyuan1,2,3 (AUTHOR), Tang, Huiyi7 (AUTHOR), Liu, Yanmin6 (AUTHOR), Liang, Li1,2,3 (AUTHOR), Ding, Yanqing1,2,3 (AUTHOR) dyq@fimmu.com, Liao, Wenting1,2,3,6 (AUTHOR) liaowt2002@gmail.com
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 9/28/2021, Vol. 40 Issue 1, p1-17. 17p.
Autor:
Ye, Liping, Lin, Chuyong, Wang, Xi, Li, Qiji, Li, Yue, Wang, Meng, Zhao, Zekun, Wu, Xianqiu, Shi, Dongni, Xiao, Yunyun, Ren, Liangliang, Jian, Yunting, Yang, Meisongzhu, Ou, Ruizhang, Deng, Guangzheng, Ouyang, Ying, Chen, Xiangfu, Li, Jun, Song, Libing
Publikováno v:
EMBO Molecular Medicine; 3/7/2022, Vol. 14 Issue 3, p1-1, 1p
Autor:
Ye, Liping, Lin, Chuyong, Wang, Xi, Li, Qiji, Li, Yue, Wang, Meng, Zhao, Zekun, Wu, Xianqiu, Shi, Dongni, Xiao, Yunyun, Ren, Liangliang, Jian, Yunting, Yang, Meisongzhu, Ou, Ruizhang, Deng, Guangzheng, Ouyang, Ying, Chen, Xiangfu, Li, Jun, Song, Libing
Publikováno v:
EMBO Molecular Medicine; Dec2019, Vol. 11 Issue 12, pN.PAG-N.PAG, 1p